Literature DB >> 35221723

Oncological Prognosis and Fertility Outcomes of Different Surgical Extents for Malignant Ovarian Sex-Cord Stromal Tumors: A Narrative Review.

Jiawei Li1, Jun Li1, Wei Jiang1.   

Abstract

BACKGROUND: Malignant ovarian sex-cord stromal tumors (MOSCSTs) are rare neoplasms that account for approximately 5-7% of all ovarian malignancies. The majority (70%) of patients had an early stage; thus, surgery is the predominant treatment. Patients were relatively young at the onset of the tumor. Moreover, the prognosis of patients with this tumor is better than that of malignant epithelial ovarian tumors and tends to recur late with an indolent clinical course. Thus, patients may be more inclined to conservative surgical procedures. There is, however, no objective criterion for selecting a suitable surgical procedure. Clinically, surgical extent depended on the preoperative evaluations, age, and willingness of patients, and gynecologists were relatively subjective when choosing surgery. The prognosis of patients with different surgical extents is still controversial. The review aimed to summarize the impacts of different surgical extents on oncological prognosis and fertility outcomes.
METHODS: The literature search was performed in PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), and publications between January 2011 and December 2021 in English including clinical cohort studies and case reports were eligible for inclusion.
RESULTS: We finally identified 12 large-sample retrospective studies and 18 cases of MOSCSTs. The primary surgical procedures include fertility-spring surgery (FSS), total hysterectomy with unilateral or bilateral salpingo-oophorectomy (TAH-USO/BSO), FSS with complete staging procedure, complete staging surgery (CSS), and debulking surgery. FSS includes cystectomy (CYS), unilateral salpingo-oophorectomy (USO) or bilateral salpingo-oophorectomy (BSO) with uterine preservation that allows for potential future assisted reproductive approaches. Complete staging procedure includes peritoneal cytologic examinations, inspections of peritoneal surfaces, random peritoneal biopsies and omentectomy. FSS with complete staging procedure means surgical procedure with uterine preservation and complete staging procedure. And, generally, CSS means TAH-BSO with complete staging procedure.
CONCLUSION: It can be concluded that USO can be done in young, fertility-desired patients with tumors confined to the ovary but avoid CYS. FSS with complete staging procedure is feasible among stage IC-III patients who have fertility desire. Patients can choose to have a complete surgery once their family is complete or without fertility requirements. CSS is recommended for patients with risk factors such as high stage, poor differentiation, and large tumor size and without fertility desire. A close follow-up is essential.
© 2022 Li et al.

Entities:  

Keywords:  fertility outcomes; malignant sex-cord stromal tumor; prognosis; risk factors; surgical extent

Year:  2022        PMID: 35221723      PMCID: PMC8864408          DOI: 10.2147/CMAR.S350457

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  85 in total

1.  Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Authors:  Melissa M Thrall; Pamela Paley; Ellen Pizer; Rochelle Garcia; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-04-09       Impact factor: 5.482

2.  Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study.

Authors:  A Bergamini; G Cormio; G Ferrandina; D Lorusso; G Giorda; G Scarfone; L Bocciolone; F Raspagliesi; S Tateo; C Cassani; A Savarese; E Breda; U De Giorgi; F Mascilini; M Candiani; A Kardhashi; N Biglia; A M Perrone; S Pignata; G Mangili
Journal:  Gynecol Oncol       Date:  2019-06-10       Impact factor: 5.482

3.  Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary.

Authors:  Dimitrios Nasioudis; Melissa K Frey; Eloise Chapman-Davis; Steven S Witkin; Kevin Holcomb
Journal:  Int J Gynecol Cancer       Date:  2017-11       Impact factor: 3.437

4.  Transvaginal natural orifice transluminal endoscopic surgery: a new approach to ovarian cystectomy.

Authors:  Jan Baekelandt
Journal:  Fertil Steril       Date:  2017-12-13       Impact factor: 7.329

5.  Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group.

Authors:  Jubilee Brown; William E Brady; Julian Schink; Linda Van Le; Mario Leitao; S Diane Yamada; Koen de Geest; David M Gershenson
Journal:  Cancer       Date:  2013-10-24       Impact factor: 6.860

6.  Prognostic Factors in Adult Granulosa Cell Tumor: A Long Follow-Up at a Single Center.

Authors:  Alper Karalok; Taner Turan; Isin Ureyen; Tolga Tasci; Derman Basaran; Sevgi Koc; Nurettin Boran; M Faruk Kose; Gokhan Tulunay
Journal:  Int J Gynecol Cancer       Date:  2016-05       Impact factor: 3.437

7.  A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature: Case report and review of literature.

Authors:  Liang Ma; Liwen Zhang; Yun Zhuang; Yanbo Ding; Jianping Chen
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  Disseminated ovarian granulosa cell tumor after laparoscopic surgery: Two case reports.

Authors:  Man-Hua Cui; Xi-Wen Zhang; Li-Ping Zhao; Shu-Yan Liu; Yan Jia
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

9.  Frequency and risk factors of bleomycin-induced pulmonary toxicity in South Indian patients with germ-cell tumors.

Authors:  Dimpal N Thakkar; Kesavan Ramasamy; Subathra Adithan; Sandhiya Selvarajan; Biswajit Dubashi
Journal:  J Cancer Res Ther       Date:  2021 Apr-Jun       Impact factor: 1.805

10.  Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report.

Authors:  Mulat Adefris; Elfalet Fekadu
Journal:  J Med Case Rep       Date:  2017-08-30
View more
  1 in total

1.  Could fertility-sparing surgery be considered for stage I ovarian sex cord-stromal tumors? A comparison of the Fine-Gray model with Cox model.

Authors:  Dan Sun; Zhi F Zhi; Jiang T Fan
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.